Benefits of sulfamethoxazole-trimethoprim prophylaxis on rates of sepsis after kidney transplant

Transplant Infectious Disease

Volumn 16, Issue 2, 2014, Pages 261-269

  Horwedel, T A ^a   Bowman, L J ^a   Saab, G ^b   Brennan, D C ^c  

^a BARNES JEWISH HOSPITAL   (United States)

^b METROHEALTH MEDICAL CENTER   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Kidney transplant; PCP; Prophylaxis; Sepsis; Sulfamethoxazole trimethoprim

Indexed keywords

ACICLOVIR; AZATHIOPRINE; CARBAPENEM; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; DOXORUBICIN; GANCICLOVIR; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NYSTATIN; PENICILLIN DERIVATIVE; PENTAMIDINE; PREDNISONE; QUINOLONE DERIVATIVE; TACROLIMUS; THYMOCYTE ANTIBODY; VALGANCICLOVIR; VINCRISTINE; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ARTICLE; BLOODSTREAM INFECTION; CATHETER INFECTION; CLINICAL PRACTICE; COHORT ANALYSIS; CYTOMEGALOVIRUS INFECTION; DELAYED GRAFT FUNCTION; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HERPES SIMPLEX; HUMAN; HYPERKALEMIA; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; SEPSIS; URINARY TRACT INFECTION; AGED; COMPLICATION; IMMUNOSUPPRESSIVE TREATMENT; MICROBIOLOGY; MIDDLE AGED;

ADULT; AGED; ANTI-INFECTIVE AGENTS; ANTIBIOTIC PROPHYLAXIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEPSIS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; URINARY TRACT INFECTIONS;

EID: 84897963547     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/tid.12196     Document Type: Article

References (22)

1. Sarnak MJ, Jaber BL. Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int 2000; 58 (4): 1758-1764.
2. Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med 2007; 357 (25): 2601-2614.
3. Fishman JA. Introduction: infection in solid organ transplant recipients. Am J Transplant 2009; 9 (Suppl 4): S3-S6.
4. Kutinova A, Woodward RS, Ricci JF, Brennan DC. The incidence and costs of sepsis and pneumonia before and after renal transplantation in the United States. Am J Transplant 2006; 6 (1): 129-139.
5. Giullian JA, Cavanaugh K, Schaefer H. Lower risk of urinary tract infection with low-dose trimethoprim/sulfamethoxazole compared to dapsone prophylaxis in older renal transplant patients on a rapid steroid-withdrawal immunosuppression regimen. Clin Transplant 2010; 24 (5): 636-642.
6. Martin SI, Fishman JA. Pneumocystis pneumonia in solid organ transplant recipients. Am J Transplant 2009; 9 (Suppl 4): S227-S233.
7. Dyner TS, Lang W, Busch DF, Gordon PR. Intravascular and pleural involvement by Pneumocystis carinii in a patient with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1989; 111 (1): 94-95.
8. Roblot F, Godet C, Le Moal G, et al. Analysis of underlying diseases and prognosis factors associated with Pneumocystis carinii pneumonia in immunocompromised HIV-negative patients. Eur J Clin Microbiol Infect Dis 2002; 21 (7): 523-531.
9. Gordon SM, LaRosa SP, Kalmadi S, et al. Should prophylaxis for Pneumocystis carinii pneumonia in solid organ transplant recipients ever be discontinued? Clin Infect Dis 1999; 28 (2): 240-246.
10. Malhotra P, Rai SD, Hirschwerk D. Duration of prophylaxis with trimethoprim-sulfamethoxazole in patients undergoing solid organ transplantation. Infection 2012; 40 (4): 473-475.
11. Wang EHZ, Partovi N, Levy RD, Shapiro RJ, Yoshida EM, Greanya ED. Pneumocystis pneumonia in solid organ transplant recipients: not yet an infection of the past. Transpl Infect Dis 2012; 14 (5): 519-525.
12. Wagenlehner F. Treatment options in nosocomial urosepsis: S409. Clin Microbiol Infect 2007; 13 (Suppl 1): 83.
13. Wagenlehner FME, Pilatz A, Naber KG, Weidner W. Therapeutic challenges of urosepsis. Eur J Clin Invest 2008; 38 (Suppl 2): 45-49.
14. Rice JC, Safdar N; the AST ID Community of Practice. Urinary tract infections in solid organ transplant recipients. Am J Transplant 2009; 9: S267-S272.
15. Horwedel T, Brennan D, Bowman L. The effects of sulfamethoxazole-trimethoprim on the incidence of sepsis after kidney transplant. Am J Transplant 2010; 10 (Suppl 4): 127.
16. Levy MM, Dellinger RP, Townsend SR, et al. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med 2010; 38 (2): 367-374.
17. Klein Klouwenberg PMC, Ong DSY, Bonten MJM, Cremer OL. Classification of sepsis, severe sepsis and septic shock: the impact of minor variations in data capture and definition of SIRS criteria. Intensive Care Med 2012; 38 (5): 811-819.
18. Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med 1998; 338 (24): 1741-1751.
19. Saemann M, Horl WH. Urinary tract infection in renal transplant recipients. Eur J Clin Invest 2008; 38 (Suppl 2): 58-65.
20. Fox BC, Sollinger HW, Belzer FO, Maki DG. A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation: clinical efficacy, absorption of trimethoprim-sulfamethoxazole, effects on the microflora, and the cost-benefit of prophylaxis. Am J Med 1990; 89 (3): 255-274.
21. Argani H, Rahnama AM, Amjadi M, Ghafari A, Bahlooli A. The role of stent and cotrimoxazole in prevention of UTI after kidney transplantation. Transplant Proc 2001; 33 (5): 2667.
22. Welling PG, Craig WA, Amidon GL, Kunin CM. Pharmacokinetics of trimethoprim and sulfamethoxazole in normal subjects and in patients with renal failure. J Infect Dis 1973; 128 (Suppl): 556-566.